To further produce tumour antigen‐specific CD8 T cells, we selected OVA‐antigen TCR (OT1, MHC‐I restricted, recognizing OVA257‐269), a well‐characterized CD8 TCR. The gene discussed is CD8A; the disease is neoplasm.